Current role
David Kupfer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Kupfer
Minerva Neurosciences, Inc. reported in an 8-K filed May 30, 2024 that David Kupfer was appointed member of the Audit Committee, effective August 6, 2024.
“Following Ms. Hilleman’s notification of resignation, the Board appointed (i) Jan van Heek, who currently serves as a member of the Audit Committee, as the new Chair of the Audit Committee and (ii) Dr. David Kupfer, a current director on the Board, as a new member of the Audit Committee, each effective upon the effective time of Ms. Hilleman’s resignation on August 6, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Minerva Neurosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Remy Luthringer CEO
- Frederick Ahlholm CFO, Chief Accounting Officer
- Joseph Reilly COO
- James O'Connor General Counsel
- James O’Connor General Counsel
- Anthony Aliquo Chief Accounting Officer
- Fouzia Laghrissi-Thode Board Member
- Inderjit Kaul Board Member
- Inderjit Kaul, M.D., MPH Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.